JP7382766B2 - Foaming solid bath additive - Google Patents
Foaming solid bath additive Download PDFInfo
- Publication number
- JP7382766B2 JP7382766B2 JP2019158607A JP2019158607A JP7382766B2 JP 7382766 B2 JP7382766 B2 JP 7382766B2 JP 2019158607 A JP2019158607 A JP 2019158607A JP 2019158607 A JP2019158607 A JP 2019158607A JP 7382766 B2 JP7382766 B2 JP 7382766B2
- Authority
- JP
- Japan
- Prior art keywords
- component
- mass
- less
- solid bath
- bath agent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000005187 foaming Methods 0.000 title claims description 36
- 239000007787 solid Substances 0.000 title claims description 28
- 239000000654 additive Substances 0.000 title description 11
- 230000000996 additive effect Effects 0.000 title description 5
- 150000007524 organic acids Chemical class 0.000 claims description 59
- 239000013041 solid bath agent Substances 0.000 claims description 53
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 29
- NOOLISFMXDJSKH-KXUCPTDWSA-N (-)-Menthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O NOOLISFMXDJSKH-KXUCPTDWSA-N 0.000 claims description 26
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 claims description 24
- 239000005022 packaging material Substances 0.000 claims description 24
- OSWPMRLSEDHDFF-UHFFFAOYSA-N methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 claims description 16
- 229920003169 water-soluble polymer Polymers 0.000 claims description 11
- 229960001047 methyl salicylate Drugs 0.000 claims description 8
- 239000002202 Polyethylene glycol Substances 0.000 claims description 7
- 239000003795 chemical substances by application Substances 0.000 claims description 7
- 229920001223 polyethylene glycol Polymers 0.000 claims description 7
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 claims description 6
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 claims description 6
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 claims description 6
- 229920001353 Dextrin Polymers 0.000 claims description 5
- 239000004375 Dextrin Substances 0.000 claims description 5
- 235000019425 dextrin Nutrition 0.000 claims description 5
- XHXUANMFYXWVNG-ADEWGFFLSA-N (-)-Menthyl acetate Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1OC(C)=O XHXUANMFYXWVNG-ADEWGFFLSA-N 0.000 claims description 4
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 claims description 4
- 239000011975 tartaric acid Substances 0.000 claims description 4
- 235000002906 tartaric acid Nutrition 0.000 claims description 4
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 claims description 3
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 claims description 3
- 239000001630 malic acid Substances 0.000 claims description 3
- 235000011090 malic acid Nutrition 0.000 claims description 3
- NFLGAXVYCFJBMK-RKDXNWHRSA-N (+)-isomenthone Natural products CC(C)[C@H]1CC[C@@H](C)CC1=O NFLGAXVYCFJBMK-RKDXNWHRSA-N 0.000 claims description 2
- 239000001605 (5-methyl-2-propan-2-ylcyclohexyl) acetate Substances 0.000 claims description 2
- XHXUANMFYXWVNG-UHFFFAOYSA-N D-menthyl acetate Natural products CC(C)C1CCC(C)CC1OC(C)=O XHXUANMFYXWVNG-UHFFFAOYSA-N 0.000 claims description 2
- NFLGAXVYCFJBMK-UHFFFAOYSA-N Menthone Chemical compound CC(C)C1CCC(C)CC1=O NFLGAXVYCFJBMK-UHFFFAOYSA-N 0.000 claims description 2
- UJNOLBSYLSYIBM-WISYIIOYSA-N [(1r,2s,5r)-5-methyl-2-propan-2-ylcyclohexyl] (2r)-2-hydroxypropanoate Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1OC(=O)[C@@H](C)O UJNOLBSYLSYIBM-WISYIIOYSA-N 0.000 claims description 2
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 claims description 2
- 229930007503 menthone Natural products 0.000 claims description 2
- 239000003205 fragrance Substances 0.000 description 21
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 20
- 239000003788 bath preparation Substances 0.000 description 16
- 238000003287 bathing Methods 0.000 description 16
- 239000003826 tablet Substances 0.000 description 12
- -1 alkaline earth metal carbonates Chemical class 0.000 description 11
- 239000001569 carbon dioxide Substances 0.000 description 10
- 229910002092 carbon dioxide Inorganic materials 0.000 description 10
- 239000007789 gas Substances 0.000 description 9
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 8
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 8
- 230000035597 cooling sensation Effects 0.000 description 8
- 239000004615 ingredient Substances 0.000 description 7
- 235000005985 organic acids Nutrition 0.000 description 6
- 238000010792 warming Methods 0.000 description 6
- 229910052783 alkali metal Inorganic materials 0.000 description 5
- 229910000288 alkali metal carbonate Inorganic materials 0.000 description 5
- 150000008041 alkali metal carbonates Chemical class 0.000 description 5
- 239000006260 foam Substances 0.000 description 5
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 4
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 4
- 229920002472 Starch Polymers 0.000 description 4
- 239000013040 bath agent Substances 0.000 description 4
- 238000011156 evaluation Methods 0.000 description 4
- 230000007794 irritation Effects 0.000 description 4
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 4
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 4
- 235000017557 sodium bicarbonate Nutrition 0.000 description 4
- 229910000029 sodium carbonate Inorganic materials 0.000 description 4
- 239000008107 starch Substances 0.000 description 4
- 235000019698 starch Nutrition 0.000 description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- 239000004480 active ingredient Substances 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000007891 compressed tablet Substances 0.000 description 3
- 238000000748 compression moulding Methods 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000010408 film Substances 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 229910052751 metal Inorganic materials 0.000 description 3
- 239000002184 metal Substances 0.000 description 3
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 238000003860 storage Methods 0.000 description 3
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 3
- JSNRRGGBADWTMC-UHFFFAOYSA-N (6E)-7,11-dimethyl-3-methylene-1,6,10-dodecatriene Chemical compound CC(C)=CCCC(C)=CCCC(=C)C=C JSNRRGGBADWTMC-UHFFFAOYSA-N 0.000 description 2
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- 239000004215 Carbon black (E152) Substances 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- MOYAFQVGZZPNRA-UHFFFAOYSA-N Terpinolene Chemical compound CC(C)=C1CCC(C)=CC1 MOYAFQVGZZPNRA-UHFFFAOYSA-N 0.000 description 2
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- UAHWPYUMFXYFJY-UHFFFAOYSA-N beta-myrcene Chemical compound CC(C)=CCCC(=C)C=C UAHWPYUMFXYFJY-UHFFFAOYSA-N 0.000 description 2
- 229910000019 calcium carbonate Inorganic materials 0.000 description 2
- CRPUJAZIXJMDBK-UHFFFAOYSA-N camphene Chemical compound C1CC2C(=C)C(C)(C)C1C2 CRPUJAZIXJMDBK-UHFFFAOYSA-N 0.000 description 2
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 239000001530 fumaric acid Substances 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 229930195733 hydrocarbon Natural products 0.000 description 2
- 150000002430 hydrocarbons Chemical class 0.000 description 2
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 229940041616 menthol Drugs 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- DNIAPMSPPWPWGF-UHFFFAOYSA-N monopropylene glycol Natural products CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 2
- XNGIFLGASWRNHJ-UHFFFAOYSA-N phthalic acid Chemical compound OC(=O)C1=CC=CC=C1C(O)=O XNGIFLGASWRNHJ-UHFFFAOYSA-N 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- FGIUAXJPYTZDNR-UHFFFAOYSA-N potassium nitrate Chemical compound [K+].[O-][N+]([O-])=O FGIUAXJPYTZDNR-UHFFFAOYSA-N 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 229960004889 salicylic acid Drugs 0.000 description 2
- 235000002639 sodium chloride Nutrition 0.000 description 2
- VWDWKYIASSYTQR-UHFFFAOYSA-N sodium nitrate Chemical compound [Na+].[O-][N+]([O-])=O VWDWKYIASSYTQR-UHFFFAOYSA-N 0.000 description 2
- 239000001384 succinic acid Substances 0.000 description 2
- OGLDWXZKYODSOB-UHFFFAOYSA-N α-phellandrene Chemical compound CC(C)C1CC=C(C)C=C1 OGLDWXZKYODSOB-UHFFFAOYSA-N 0.000 description 2
- YHQGMYUVUMAZJR-UHFFFAOYSA-N α-terpinene Chemical compound CC(C)C1=CC=C(C)CC1 YHQGMYUVUMAZJR-UHFFFAOYSA-N 0.000 description 2
- CXENHBSYCFFKJS-UHFFFAOYSA-N (3E,6E)-3,7,11-Trimethyl-1,3,6,10-dodecatetraene Natural products CC(C)=CCCC(C)=CCC=C(C)C=C CXENHBSYCFFKJS-UHFFFAOYSA-N 0.000 description 1
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- 239000001169 1-methyl-4-propan-2-ylcyclohexa-1,4-diene Substances 0.000 description 1
- RTBFRGCFXZNCOE-UHFFFAOYSA-N 1-methylsulfonylpiperidin-4-one Chemical compound CS(=O)(=O)N1CCC(=O)CC1 RTBFRGCFXZNCOE-UHFFFAOYSA-N 0.000 description 1
- ODHCTXKNWHHXJC-UHFFFAOYSA-N 5-oxoproline Chemical compound OC(=O)C1CCC(=O)N1 ODHCTXKNWHHXJC-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
- 239000004484 Briquette Substances 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 229920000623 Cellulose acetate phthalate Polymers 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- WTEVQBCEXWBHNA-UHFFFAOYSA-N Citral Natural products CC(C)=CCCC(C)=CC=O WTEVQBCEXWBHNA-UHFFFAOYSA-N 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- VLXDPFLIRFYIME-GZBLMMOJSA-N Copaene Natural products C1C=C(C)[C@H]2[C@]3(C)CC[C@H](C(C)C)[C@H]2[C@@H]31 VLXDPFLIRFYIME-GZBLMMOJSA-N 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- 229920000161 Locust bean gum Polymers 0.000 description 1
- PDSNLYSELAIEBU-UHFFFAOYSA-N Longifolene Chemical compound C1CCC(C)(C)C2C3CCC2C1(C)C3=C PDSNLYSELAIEBU-UHFFFAOYSA-N 0.000 description 1
- ZPUKHRHPJKNORC-UHFFFAOYSA-N Longifolene Natural products CC1(C)CCCC2(C)C3CCC1(C3)C2=C ZPUKHRHPJKNORC-UHFFFAOYSA-N 0.000 description 1
- WSTYNZDAOAEEKG-UHFFFAOYSA-N Mayol Natural products CC1=C(O)C(=O)C=C2C(CCC3(C4CC(C(CC4(CCC33C)C)=O)C)C)(C)C3=CC=C21 WSTYNZDAOAEEKG-UHFFFAOYSA-N 0.000 description 1
- 239000008118 PEG 6000 Substances 0.000 description 1
- 229920002584 Polyethylene Glycol 6000 Polymers 0.000 description 1
- 229920002873 Polyethylenimine Polymers 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- PXRCIOIWVGAZEP-UHFFFAOYSA-N Primaeres Camphenhydrat Natural products C1CC2C(O)(C)C(C)(C)C1C2 PXRCIOIWVGAZEP-UHFFFAOYSA-N 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 240000004584 Tamarindus indica Species 0.000 description 1
- 235000004298 Tamarindus indica Nutrition 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 230000002730 additional effect Effects 0.000 description 1
- 239000001361 adipic acid Substances 0.000 description 1
- 235000011037 adipic acid Nutrition 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 229940072056 alginate Drugs 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- 150000005215 alkyl ethers Chemical class 0.000 description 1
- XCPQUQHBVVXMRQ-UHFFFAOYSA-N alpha-Fenchene Natural products C1CC2C(=C)CC1C2(C)C XCPQUQHBVVXMRQ-UHFFFAOYSA-N 0.000 description 1
- VYBREYKSZAROCT-UHFFFAOYSA-N alpha-myrcene Natural products CC(=C)CCCC(=C)C=C VYBREYKSZAROCT-UHFFFAOYSA-N 0.000 description 1
- OGLDWXZKYODSOB-SNVBAGLBSA-N alpha-phellandrene Natural products CC(C)[C@H]1CC=C(C)C=C1 OGLDWXZKYODSOB-SNVBAGLBSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- JFCQEDHGNNZCLN-UHFFFAOYSA-N anhydrous glutaric acid Natural products OC(=O)CCCC(O)=O JFCQEDHGNNZCLN-UHFFFAOYSA-N 0.000 description 1
- 239000000305 astragalus gummifer gum Substances 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000005587 bubbling Effects 0.000 description 1
- 239000000378 calcium silicate Substances 0.000 description 1
- 229910052918 calcium silicate Inorganic materials 0.000 description 1
- OYACROKNLOSFPA-UHFFFAOYSA-N calcium;dioxido(oxo)silane Chemical compound [Ca+2].[O-][Si]([O-])=O OYACROKNLOSFPA-UHFFFAOYSA-N 0.000 description 1
- 229930006739 camphene Natural products 0.000 description 1
- ZYPYEBYNXWUCEA-UHFFFAOYSA-N camphenilone Natural products C1CC2C(=O)C(C)(C)C1C2 ZYPYEBYNXWUCEA-UHFFFAOYSA-N 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- IRAQOCYXUMOFCW-CXTNEJHOSA-N cedrene Chemical compound C1[C@]23[C@H](C)CC[C@H]3C(C)(C)[C@H]1C(C)=CC2 IRAQOCYXUMOFCW-CXTNEJHOSA-N 0.000 description 1
- 229940081734 cellulose acetate phthalate Drugs 0.000 description 1
- 229940043350 citral Drugs 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- VLXDPFLIRFYIME-BTFPBAQTSA-N copaene Chemical compound C1C=C(C)[C@H]2[C@]3(C)CC[C@@H](C(C)C)[C@H]2[C@@H]31 VLXDPFLIRFYIME-BTFPBAQTSA-N 0.000 description 1
- 239000000645 desinfectant Substances 0.000 description 1
- IRAQOCYXUMOFCW-UHFFFAOYSA-N di-epi-alpha-cedrene Natural products C1C23C(C)CCC3C(C)(C)C1C(C)=CC2 IRAQOCYXUMOFCW-UHFFFAOYSA-N 0.000 description 1
- KCIDZIIHRGYJAE-YGFYJFDDSA-L dipotassium;[(2r,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] phosphate Chemical compound [K+].[K+].OC[C@H]1O[C@H](OP([O-])([O-])=O)[C@H](O)[C@@H](O)[C@H]1O KCIDZIIHRGYJAE-YGFYJFDDSA-L 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 229930009668 farnesene Natural products 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- WTEVQBCEXWBHNA-JXMROGBWSA-N geranial Chemical compound CC(C)=CCC\C(C)=C\C=O WTEVQBCEXWBHNA-JXMROGBWSA-N 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 229910017053 inorganic salt Inorganic materials 0.000 description 1
- 229910000358 iron sulfate Inorganic materials 0.000 description 1
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 150000002596 lactones Chemical class 0.000 description 1
- 235000001510 limonene Nutrition 0.000 description 1
- 229940087305 limonene Drugs 0.000 description 1
- 235000010420 locust bean gum Nutrition 0.000 description 1
- 239000000711 locust bean gum Substances 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L magnesium chloride Substances [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 229910044991 metal oxide Inorganic materials 0.000 description 1
- 150000004706 metal oxides Chemical class 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 150000007823 ocimene derivatives Chemical class 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000013808 oxidized starch Nutrition 0.000 description 1
- 239000001254 oxidized starch Substances 0.000 description 1
- HFPZCAJZSCWRBC-UHFFFAOYSA-N p-cymene Chemical compound CC(C)C1=CC=C(C)C=C1 HFPZCAJZSCWRBC-UHFFFAOYSA-N 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 229940127557 pharmaceutical product Drugs 0.000 description 1
- 150000007875 phellandrene derivatives Chemical class 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229960003975 potassium Drugs 0.000 description 1
- 235000007686 potassium Nutrition 0.000 description 1
- 229910000028 potassium bicarbonate Inorganic materials 0.000 description 1
- 235000015497 potassium bicarbonate Nutrition 0.000 description 1
- 239000011736 potassium bicarbonate Substances 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 235000011181 potassium carbonates Nutrition 0.000 description 1
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 1
- 229940086066 potassium hydrogencarbonate Drugs 0.000 description 1
- 239000004323 potassium nitrate Substances 0.000 description 1
- 235000010333 potassium nitrate Nutrition 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 229930004725 sesquiterpene Natural products 0.000 description 1
- 150000004354 sesquiterpene derivatives Chemical class 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000004317 sodium nitrate Substances 0.000 description 1
- 235000010344 sodium nitrate Nutrition 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 229910000162 sodium phosphate Inorganic materials 0.000 description 1
- 235000019830 sodium polyphosphate Nutrition 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- AKHNMLFCWUSKQB-UHFFFAOYSA-L sodium thiosulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=S AKHNMLFCWUSKQB-UHFFFAOYSA-L 0.000 description 1
- 235000019345 sodium thiosulphate Nutrition 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 229920000247 superabsorbent polymer Polymers 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 150000003505 terpenes Chemical class 0.000 description 1
- 235000007586 terpenes Nutrition 0.000 description 1
- 229930006978 terpinene Natural products 0.000 description 1
- 150000003507 terpinene derivatives Chemical class 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- XJPBRODHZKDRCB-UHFFFAOYSA-N trans-alpha-ocimene Natural products CC(=C)CCC=C(C)C=C XJPBRODHZKDRCB-UHFFFAOYSA-N 0.000 description 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
Description
本発明は、発泡性固体浴用剤に関する。 The present invention relates to foamable solid bath preparations.
炭酸塩と有機酸を配合した発泡性浴用剤は、浴水中で炭酸ガスの泡を発生し、発泡感を楽しむことができると共に、炭酸ガスによる温まり感、血行促進効果が得られることが知られている。またこうした浴用剤に、さらに種々の成分を配合することで、付加的効果や相乗的効果をもたらす研究もなされている。例えば、浴用剤においては、入浴することによって冷涼感が得られるようにするためメントールを配合することが行われている。
特許文献1には、浴用剤として、金属無機塩と高吸水性高分子を主成分とする浴用剤に、殺菌剤としてサリチル酸、サリチル酸メチル、グリチルリチル酸ジカリウム、パラベンなどから選択される1種以上;炭酸ガス発生剤として有機酸とアルカリ;高揮発性成分としてl-メントールやdl-カンフルなどが配合される足用入浴剤が開示されている。
Foaming bath additives containing carbonates and organic acids are known to generate carbon dioxide bubbles in the bath water, allowing you to enjoy the foaming sensation, as well as providing a warming feeling and blood circulation promoting effect due to the carbon dioxide gas. ing. Research has also been conducted to create additional or synergistic effects by incorporating various ingredients into these bath preparations. For example, menthol is added to bath preparations in order to provide a cooling sensation when taking a bath.
Patent Document 1 describes a bath agent containing a metal inorganic salt and a superabsorbent polymer as main components, and one or more disinfectants selected from salicylic acid, methyl salicylate, dipotassium glycyrrhizylate, paraben, etc.; A foot bath additive is disclosed that contains an organic acid and an alkali as a carbon dioxide gas generating agent, and l-menthol, dl-camphor, etc. as highly volatile ingredients.
炭酸塩と有機酸を配合した発泡性浴用剤においては、20℃の水100mLへの溶解度が5g以上である有機酸のように、水への溶解度が高い有機酸を用いると浴水中で浴用剤が速く溶けるため発泡が速く、入浴時の温まりが速くなり、浴用剤が溶け始めるときの発泡強さは得られるという利点がある。しかしながら、炭酸ガスの発泡により、粘膜刺激性のある有機酸が飛散し、これを吸い込むことによって、「むせ」(入浴時のむせ)を生じるという問題がある。
特許文献1にはl-メントールと炭酸ガス発生剤を配合した浴用剤が開示されているが、炭酸ガス発生剤の配合量が少なく良好な発泡性が得られない。そのため発泡性を維持するために炭酸ガス発生剤の配合量を増やすとl-メントールによる刺激を伴った香りが強くなる。更にl-メントールを配合した浴用剤に、水への溶解度が高い有機酸を配合すると、該有機酸とl-メントールの両成分による入浴時のむせがより強く生じ、さらに浴用剤を封入した浴用剤製品の包材を開封する際にもl-メントールによる「むせ」(開封時のむせ)が生じるという問題がある。
本発明は、発泡成分として水への溶解度が高い有機酸を用い、さらに、l-メントール又はその誘導体を含有させた発泡性固体浴用剤、及び該発泡性固体浴用剤を包材に封入した発泡性固体浴用剤製品において、包材開封時及び入浴時のむせを抑制することを課題とする。
In foaming bath additives containing carbonates and organic acids, if an organic acid with high solubility in water is used, such as an organic acid with a solubility of 5 g or more in 100 mL of water at 20°C, the bath additive will not dissolve in the bath water. It has the advantage that it foams quickly because it melts quickly, so it warms up quickly during bathing, and the foaming strength is achieved when the bath additive starts to melt. However, there is a problem in that bubbling of carbon dioxide gas scatters organic acids that irritate the mucous membranes, which can be inhaled, resulting in ``choking'' (choking during bathing).
Patent Document 1 discloses a bath agent containing l-menthol and a carbon dioxide gas generating agent, but the amount of carbon dioxide gas generating agent blended is small and good foaming properties cannot be obtained. Therefore, if the amount of carbon dioxide gas generator is increased in order to maintain foaming properties, the irritating aroma caused by l-menthol will become stronger. Furthermore, if an organic acid with high solubility in water is added to a bath agent containing l-menthol, the choking caused by both the organic acid and l-menthol will be stronger. There is also a problem in that ``choking'' (choking when opening) occurs due to l-menthol when opening the packaging material of pharmaceutical products.
The present invention provides a foaming solid bath agent using an organic acid with high solubility in water as a foaming component and further containing l-menthol or its derivative, and a foaming solid bath agent containing the foaming solid bath agent in a packaging material. The objective of the present invention is to suppress choking when opening the package and when taking a bath in a solid bath preparation product.
本発明者は、水への溶解度の高い有機酸と、炭酸塩と、l-メントール又はその誘導体(以下、l-メントール等ともいう)とを含有する発泡性固体浴用剤において、さらにサリチル酸メチル及び所定の水溶性高分子を所定の範囲で含有することで、上記課題を解決できることを見出した。
すなわち本発明は、下記[1]及び[2]に関する。
[1]下記成分(A)、(B)、(C)、(D)、及び(E):
(A)20℃の水100mLへの溶解度が5g以上である有機酸(A1)を含む有機酸
(B)炭酸塩
(C)l-メントール又はその誘導体
(D)サリチル酸メチル
(E)25℃で固体の水溶性高分子
を含有し、
成分(D)に対する成分(A)及び成分(C)の合計の質量比[{(A)+(C)}/(D)]が50以上1000以下であり、成分(E)に対する成分(C)の質量比[(C)/(E)]が0.01以上10以下である、発泡性固体浴用剤。
[2]上記[1]の発泡性固体浴用剤を包材に封入した発泡性固体浴用剤製品。
The present inventor has proposed a foaming solid bath agent containing an organic acid with high solubility in water, a carbonate, and l-menthol or a derivative thereof (hereinafter also referred to as l-menthol etc.), which further contains methyl salicylate and It has been found that the above problems can be solved by containing a predetermined water-soluble polymer within a predetermined range.
That is, the present invention relates to the following [1] and [2].
[1] The following components (A), (B), (C), (D), and (E):
(A) An organic acid containing an organic acid (A1) having a solubility of 5 g or more in 100 mL of water at 20°C (B) Carbonate (C) l-menthol or its derivative (D) Methyl salicylate (E) At 25°C Contains a solid water-soluble polymer,
The mass ratio of the sum of component (A) and component (C) to component (D) [{(A)+(C)}/(D)] is 50 or more and 1000 or less, and the component (C) to component (E) is ) A foaming solid bath agent having a mass ratio [(C)/(E)] of 0.01 or more and 10 or less.
[2] A foaming solid bathing agent product in which the foaming solid bathing agent of [1] above is encapsulated in a packaging material.
本発明によれば、l-メントール等による冷涼感が得られ、浴水中での発泡が速く、かつ、包材開封時及び入浴時のむせが抑制された発泡性固体浴用剤、及び該発泡性固体浴用剤を包材に封入した発泡性固体浴用剤製品を提供できる。 According to the present invention, there is provided a foaming solid bath agent that provides a cooling sensation due to l-menthol, etc., foams quickly in bath water, and suppresses choking when opening a packaging material and when taking a bath; It is possible to provide a foamable solid bath agent product in which a solid bath agent is encapsulated in a packaging material.
[発泡性固体浴用剤/発泡性固体浴用剤製品]
本発明の発泡性固体浴用剤(以下、単に「固体浴用剤」ともいう)は、下記成分(A)、(B)、(C)、(D)、及び(E):
(A)20℃の水100mLへの溶解度が5g以上である有機酸(A1)を含む有機酸
(B)炭酸塩
(C)l-メントール又はその誘導体
(D)サリチル酸メチル
(E)25℃で固体の水溶性高分子
を含有し、
成分(D)に対する成分(A)及び成分(C)の合計の質量比[{(A)+(C)}/(D)]が50以上1000以下であり、成分(E)に対する成分(C)の質量比[(C)/(E)]が0.01以上10以下である。
本発明の発泡性固体浴用剤製品(以下、単に「固体浴用剤製品」ともいう)は、該発泡性固体浴用剤を包材に封入してなるものである。
[Foaming solid bath agent/Foaming solid bath agent product]
The foamable solid bath agent of the present invention (hereinafter also simply referred to as "solid bath agent") has the following components (A), (B), (C), (D), and (E):
(A) An organic acid containing an organic acid (A1) having a solubility of 5 g or more in 100 mL of water at 20°C (B) Carbonate (C) l-menthol or its derivative (D) Methyl salicylate (E) At 25°C Contains a solid water-soluble polymer,
The mass ratio of the sum of component (A) and component (C) to component (D) [{(A)+(C)}/(D)] is 50 or more and 1000 or less, and the component (C) to component (E) is ) has a mass ratio [(C)/(E)] of 0.01 or more and 10 or less.
The foamable solid bath agent product of the present invention (hereinafter also simply referred to as "solid bath agent product") is obtained by encapsulating the foamable solid bath agent in a packaging material.
本発明の発泡性固体浴用剤は上記構成とすることにより、成分(A)である、水への溶解度が高い有機酸(A1)を含む有機酸と、成分(C)であるl-メントール又はその誘導体とを含有する発泡性固体浴用剤においても、包材開封時及び入浴時のむせを抑制したものとなる。その理由は必ずしも明らかではないが、次のように考えられる。
発泡性固体浴用剤による入浴時のむせは、主として成分(A)及び成分(C)に起因して生じると考えられる。すなわち、発泡成分として、成分(A)中に含まれる水への溶解度が高い有機酸(A1)と、成分(B)との作用により浴水中で急激に溶解及び発泡し、成分(C)の刺激を伴う香りと相まって入浴時にむせやすくなると考えられる。しかしながら、成分(D)に対する成分(A)及び成分(C)の合計の質量比[{(A)+(C)}/(D)]を上記範囲とすることで、成分(D)の香りによりl-メントール等の清涼感を助長しながら、l-メントール等との相溶性に優れることによりl-メントール等の揮散を抑制し、入浴時のむせを抑えることができたものと考えられる。
また、発泡性固体浴用剤による包材開封時のむせは、主として成分(C)の刺激を伴った香りに起因して生じると考えられるが、成分(E)に対する成分(C)の質量比[(C)/(E)]を上記範囲とすることで、成分(E)に成分(C)が安定に担持され、これにより包材開封時のむせを抑えることができたものと考えられる。
The foaming solid bath agent of the present invention has the above-mentioned structure, so that the component (A) is an organic acid containing an organic acid (A1) having high solubility in water, and the component (C) is l-menthol or A foaming solid bath preparation containing the derivative also suppresses choking when opening the packaging material and when taking a bath. Although the reason is not necessarily clear, it is thought to be as follows.
It is thought that choking during bathing due to foaming solid bath additives is mainly caused by components (A) and (C). That is, as a foaming component, the organic acid (A1) that is highly soluble in water contained in component (A) and component (B) rapidly dissolve and foam in the bath water due to the action of component (C). It is thought that this, combined with the irritating scent, makes it easier to choke when taking a bath. However, by setting the mass ratio of the sum of component (A) and component (C) to component (D) [{(A)+(C)}/(D)] within the above range, the fragrance of component (D) It is thought that this product is able to promote the cooling sensation of l-menthol and the like, while suppressing volatilization of l-menthol and the like due to its excellent compatibility with l-menthol and the like, thereby suppressing choking during bathing.
Furthermore, choking caused by foaming solid bath additives when opening the packaging material is thought to be mainly caused by the irritating scent of component (C), but the mass ratio of component (C) to component (E) [ (C)/(E)] within the above range, component (C) was stably supported on component (E), and it is believed that this made it possible to suppress choking when the packaging material was opened.
以下、本発明における発泡性固体浴用剤に含有される各成分について説明する。
<成分(A):有機酸(A1)を含む有機酸>
本発明の固体浴用剤は、成分(A)として、20℃の水100mLへの溶解度が5g以上である有機酸(A1)(以下、単に「有機酸(A1)」又は「成分(A1)」ともいう)を含む有機酸を含有する。本発明の固体浴用剤は成分(A)を含有することで、後述する成分(B)との作用により炭酸ガスを発生させ、血行促進効果をもたらすとともに良好な温まり速さを付与することができる。また成分(A)は有機酸(A1)を含むことにより、浴水への溶解が速く、炭酸ガスの発泡が速やかに起こる。なお、本明細書において、「水への溶解度が高い有機酸」とは、20℃の水100mLへの溶解度が5g以上である有機酸を意味する。また、発泡性とは、浴用剤が速やかに浴水中で溶解し発泡することを意味する。
Each component contained in the foamable solid bath agent of the present invention will be explained below.
<Component (A): Organic acid containing organic acid (A1)>
The solid bath agent of the present invention contains, as component (A), an organic acid (A1) having a solubility in 100 mL of water at 20°C of 5 g or more (hereinafter simply referred to as "organic acid (A1)" or "component (A1)"). Contains organic acids including By containing the component (A), the solid bath agent of the present invention can generate carbon dioxide gas through the action with the component (B) described below, thereby providing a blood circulation promoting effect and a good warming speed. . Furthermore, since the component (A) contains the organic acid (A1), it is quickly dissolved in the bath water, and carbon dioxide gas is rapidly generated. In this specification, "organic acid with high solubility in water" means an organic acid with solubility in 100 mL of water at 20° C. of 5 g or more. Moreover, foamability means that the bath agent quickly dissolves and foams in bath water.
有機酸(A1)としては、コハク酸(5.8)、酒石酸(21)、酒石酸の異性体であるL-酒石酸(139)、リンゴ酸(56)、クエン酸(73)、マレイン酸(78)、グルタル酸(43)DL-2-ピロリドン-5-カルボン酸(5.67)等が挙げられ、これらを単独で又は2種以上組み合わせて含有することができる。なかでも、良好な温まり速さ及び発泡性を付与する観点から、コハク酸、酒石酸、L-酒石酸、及びリンゴ酸からなる群から選ばれる1種以上が好ましく、保存安定性を向上させる観点から、コハク酸を含有することがより好ましい。なお、各有機酸の後ろのカッコ内の数値はそれぞれの20℃の水100mLへの溶解度(単位:g/100mL-H2O)である。 Examples of organic acids (A1) include succinic acid (5.8), tartaric acid (21), L-tartaric acid (139), which is an isomer of tartaric acid, malic acid (56), citric acid (73), and maleic acid (78). ), glutaric acid (43), DL-2-pyrrolidone-5-carboxylic acid (5.67), etc., and these can be contained alone or in combination of two or more. Among them, from the viewpoint of imparting good warming speed and foaming properties, one or more selected from the group consisting of succinic acid, tartaric acid, L-tartaric acid, and malic acid is preferable, and from the viewpoint of improving storage stability, It is more preferable to contain succinic acid. The numerical value in parentheses after each organic acid is its solubility in 100 mL of water at 20° C. (unit: g/100 mL-H 2 O).
本発明の固体浴用剤に含まれる成分(A)中の有機酸(A1)の含有量は、発泡性を付与する観点から、好ましくは30質量%以上であり、より好ましくは50質量%以上であり、さらに好ましくは75質量%以上であり、よりさらに好ましくは95質量%以上であり、そして好ましくは実質100質量%以下である。
本発明の固体浴用剤における成分(A)は有機酸(A1)の含有量が100質量%、すなわち有機酸(A1)のみからなるものであってもよい。
The content of the organic acid (A1) in the component (A) contained in the solid bath agent of the present invention is preferably 30% by mass or more, more preferably 50% by mass or more, from the viewpoint of imparting foaming properties. The content is preferably 75% by mass or more, even more preferably 95% by mass or more, and preferably substantially 100% by mass or less.
Component (A) in the solid bath agent of the present invention may have an organic acid (A1) content of 100% by mass, that is, it may consist only of the organic acid (A1).
本発明の固体浴用剤における成分(A)は、有機酸(A1)以外の有機酸(A2)(以下、単に「有機酸(A2)」ともいう)を含有していてもよい。有機酸(A2)は、20℃の水100mLへの溶解度が5g未満の有機酸である。かかる有機酸(A2)としては、フマル酸(0.6)、アジピン酸(1.5)、安息香酸(0.3)、フタル酸(0,7)、サリチル酸(0.2)等が挙げられ、これらを単独で又は2種以上組み合わせて含有することができる。なかでも、保存安定性の観点、及び入浴時のむせを抑制する観点から、フマル酸が好ましい。なお、各有機酸の後ろのカッコ内の数値はそれぞれの20℃の水100mLへの溶解度(単位:g/100mL-H2O)である。
本発明の固体浴用剤に有機酸(A2)を含む場合、成分(A)中の有機酸(A2)の含有量は、浴水中での発泡速さを確保する観点から、好ましくは70質量%以下であり、より好ましくは50質量%以下であり、さらに好ましくは25質量%以下あり、よりさらに好ましくは5質量%以下である。
Component (A) in the solid bath agent of the present invention may contain an organic acid (A2) other than the organic acid (A1) (hereinafter also simply referred to as "organic acid (A2)"). The organic acid (A2) is an organic acid having a solubility in 100 mL of water at 20° C. of less than 5 g. Examples of such organic acids (A2) include fumaric acid (0.6), adipic acid (1.5), benzoic acid (0.3), phthalic acid (0.7), and salicylic acid (0.2). These may be contained alone or in combination of two or more. Among these, fumaric acid is preferred from the viewpoint of storage stability and prevention of choking during bathing. The numerical value in parentheses after each organic acid is its solubility in 100 mL of water at 20° C. (unit: g/100 mL-H 2 O).
When the solid bath agent of the present invention contains an organic acid (A2), the content of the organic acid (A2) in the component (A) is preferably 70% by mass from the viewpoint of ensuring foaming speed in bath water. The content is preferably at most 50% by mass, still more preferably at most 25% by mass, even more preferably at most 5% by mass.
本発明の固体浴用剤中の成分(A)の含有量は、良好な温まり速さ及び発泡性を付与する観点から、好ましくは5質量%以上であり、より好ましくは20質量%以上、さらに好ましくは30質量%以上、よりさらに好ましくは40質量%以上、よりさらに好ましくは45質量%以上である。また、本発明の固体浴用剤中の成分(A)の含有量は、良好な温まり速さ及び発泡性を付与しつつ、入浴時のむせを抑制する観点から、好ましくは70質量%以下、より好ましくは65質量%以下、さらに好ましくは55質量%以下である。 The content of component (A) in the solid bath agent of the present invention is preferably 5% by mass or more, more preferably 20% by mass or more, and even more preferably is 30% by mass or more, even more preferably 40% by mass or more, even more preferably 45% by mass or more. Further, the content of component (A) in the solid bath agent of the present invention is preferably 70% by mass or less, and more Preferably it is 65% by mass or less, more preferably 55% by mass or less.
<成分(B):炭酸塩>
本発明の固体浴用剤は、成分(B)として、炭酸塩を含有する。成分(B)は、本発明の固体浴用剤を浴水に投入した際に、成分(A)との作用により炭酸ガスを発生させ、血行促進効果をもたらすとともに良好な温まり速さを付与することができる。
成分(B)としては、炭酸ナトリウム、炭酸カリウム等のアルカリ金属炭酸塩;炭酸カルシウム、炭酸マグネシウム等のアルカリ土類金属炭酸塩;及び、炭酸水素ナトリウム、炭酸水素カリウム等のアルカリ金属重炭酸塩;等が挙げられ、これらを単独で又は2種以上組み合わせて含有することができる。なかでも、良好な成形性、温まり速さ及び発泡性を付与する観点から、炭酸ナトリウム、炭酸水素ナトリウム、及び炭酸カルシウムからなる群から選ばれる1種以上が好ましく、炭酸ナトリウム及び炭酸水素ナトリウムからなる群から選ばれる1種又は2種がより好ましい。
成分(B)は、良好な成形性を付与する観点からはアルカリ金属炭酸塩を含むことが好ましく、温まり速さ及び良好な発泡性を付与する観点からはアルカリ金属重炭酸塩を含むことが好ましい。すなわち成分(B)としては、アルカリ金属炭酸塩とアルカリ金属重炭酸塩とを含有することが好ましく、炭酸ナトリウムと炭酸水素ナトリウムとを含有することがより好ましい。
<Component (B): carbonate>
The solid bath agent of the present invention contains a carbonate as component (B). Component (B) generates carbon dioxide gas by interacting with component (A) when the solid bath agent of the present invention is added to bath water, thereby promoting a blood circulation effect and imparting a good warming speed. I can do it.
Component (B) includes alkali metal carbonates such as sodium carbonate and potassium carbonate; alkaline earth metal carbonates such as calcium carbonate and magnesium carbonate; and alkali metal bicarbonates such as sodium hydrogen carbonate and potassium hydrogen carbonate; These may be contained alone or in combination of two or more. Among these, from the viewpoint of imparting good moldability, heating speed, and foamability, one or more selected from the group consisting of sodium carbonate, sodium hydrogen carbonate, and calcium carbonate is preferred, and sodium carbonate and sodium hydrogen carbonate are preferred. One or two selected from the group is more preferred.
Component (B) preferably contains an alkali metal carbonate from the perspective of imparting good moldability, and preferably contains an alkali metal bicarbonate from the perspective of imparting warming speed and good foamability. . That is, component (B) preferably contains an alkali metal carbonate and an alkali metal bicarbonate, and more preferably contains sodium carbonate and sodium hydrogen carbonate.
成分(B)としてアルカリ金属炭酸塩とアルカリ金属重炭酸塩とを併用する場合、その比率は特に制限されないが、良好な成形性、温まり速さ及び発泡性を付与する観点から、金属炭酸塩に対する金属重炭酸の質量比として[アルカリ金属重炭酸塩/アルカリ金属炭酸塩]は、好ましくは0.2以上、より好ましくは0.3以上、さらに好ましくは0.5以上であり、好ましくは4.0以下、より好ましくは2.0以下、さらに好ましくは1.5以下である。 When using an alkali metal carbonate and an alkali metal bicarbonate together as component (B), the ratio is not particularly limited, but from the viewpoint of imparting good moldability, heating speed, and foamability, The mass ratio of metal bicarbonate [alkali metal bicarbonate/alkali metal carbonate] is preferably 0.2 or more, more preferably 0.3 or more, still more preferably 0.5 or more, and preferably 4. It is 0 or less, more preferably 2.0 or less, even more preferably 1.5 or less.
本発明の固体浴用剤中の成分(B)の含有量は、良好な温まり速さ及び発泡性を付与する観点から、好ましくは10質量%以上、より好ましくは15質量%以上、さらに好ましくは20質量%以上、よりさらに好ましくは25質量%以上、さらにより好ましくは30質量%以上であり、また、好ましくは65質量%以下、より好ましくは60質量%以下、さらに好ましくは55質量%以下、よりさらに好ましくは50質量%以下である。 The content of component (B) in the solid bath agent of the present invention is preferably 10% by mass or more, more preferably 15% by mass or more, still more preferably 20% by mass or more, from the viewpoint of imparting good warming speed and foaming properties. % by mass or more, even more preferably 25% by mass or more, even more preferably 30% by mass or more, and preferably 65% by mass or less, more preferably 60% by mass or less, still more preferably 55% by mass or less, More preferably, it is 50% by mass or less.
本発明の固体浴用剤中の成分(A1)に対する成分(B)の質量比[(B)/(A1)]は、入浴時のむせを抑制する観点から、好ましくは0.5以上、より好ましくは0.6以上、さらに好ましくは0.8以上である。また、質量比[(B)/(A1)]は、発泡性を付与する観点から、好ましくは4以下、より好ましくは2以下、さらにより好ましくは1.0以下、よりさらに好ましくは0.9以下である。 The mass ratio [(B)/(A1)] of component (B) to component (A1) in the solid bath agent of the present invention is preferably 0.5 or more, more preferably 0.5 or more, from the viewpoint of suppressing choking during bathing. is 0.6 or more, more preferably 0.8 or more. In addition, from the viewpoint of imparting foamability, the mass ratio [(B)/(A1)] is preferably 4 or less, more preferably 2 or less, even more preferably 1.0 or less, and even more preferably 0.9. It is as follows.
<成分(C):l-メントール又はその誘導体>
本発明の固体浴用剤は、成分(C)としてl-メントール又はその誘導体を含有する。かかる成分(C)を含有することにより、良好な冷涼感を付与することができる。l-メントールの誘導体としては、例えば、乳酸メンチル、酢酸メンチル、メントン等が挙げられる。成分(C)のl-メントール又はその誘導体は、1種又は2種以上含有することができ、なかでもl-メントールが好ましい。
本発明の固体浴用剤中の成分(C)の含有量は、良好な冷涼感をもたらし、かつこれを持続させる観点から、好ましくは0.04質量%以上であり、より好ましくは0.1質量%以上であり、さらに好ましくは0.2質量%以上である。また、成分(C)の含有量は、包材開封時および入浴時のむせを抑制する観点から、好ましくは1.5質量%以下であり、より好ましくは1.0質量%以下であり、さらに好ましくは0.8質量%以下であり、よりさらに好ましくは0.6質量%以下である。
<Component (C): l-menthol or its derivative>
The solid bath agent of the present invention contains l-menthol or a derivative thereof as component (C). By containing such component (C), a good cooling sensation can be imparted. Examples of l-menthol derivatives include menthyl lactate, menthyl acetate, and menthone. Component (C), l-menthol or its derivatives, may contain one or more types, and l-menthol is particularly preferred.
The content of component (C) in the solid bath agent of the present invention is preferably 0.04% by mass or more, more preferably 0.1% by mass, from the viewpoint of providing a good cooling sensation and sustaining this feeling. % or more, more preferably 0.2% by mass or more. In addition, the content of component (C) is preferably 1.5% by mass or less, more preferably 1.0% by mass or less, and Preferably it is 0.8% by mass or less, and even more preferably 0.6% by mass or less.
<成分(D):サリチル酸メチル>
本発明の固体浴用剤は、成分(D)としてサリチル酸メチルを含有する。かかる成分(D)を含有することによって、前述した作用機構により、入浴時に成分(A)及び成分(C)によって生じるむせを抑制することができる。また成分(D)に由来する特有の香りによる清涼感を付与することができ、スポーツ等の運動後の疲労回復効果が得られることも期待できる。
本発明の固体浴用剤中の成分(D)の含有量は、入浴時のむせを抑制する観点、及び、良好な清涼感をもたらす観点から、好ましくは0.01質量%以上であり、より好ましくは0.05質量%以上であり、さらに好ましくは0.10質量%以上であり、よりさらに好ましくは0.12質量%以上である。また、成分(D)の含有量は、成分(A)~(C)に由来する効果を確保する観点から、好ましくは1質量%以下であり、より好ましくは0.8質量%以下であり、さらに好ましくは0.5質量%以下であり、よりさらに好ましくは0.3質量%以下である。
<Component (D): Methyl salicylate>
The solid bath agent of the present invention contains methyl salicylate as component (D). By containing such component (D), choking caused by component (A) and component (C) during bathing can be suppressed due to the above-described mechanism of action. In addition, it is possible to impart a refreshing feeling due to the unique aroma derived from component (D), and it can also be expected that the effect of recovering from fatigue after exercise such as sports can be obtained.
The content of component (D) in the solid bath preparation of the present invention is preferably 0.01% by mass or more, more preferably 0.01% by mass or more, from the viewpoint of suppressing choking during bathing and providing a good refreshing feeling. is 0.05% by mass or more, more preferably 0.10% by mass or more, even more preferably 0.12% by mass or more. Further, the content of component (D) is preferably 1% by mass or less, more preferably 0.8% by mass or less, from the viewpoint of ensuring the effects derived from components (A) to (C). More preferably, it is 0.5% by mass or less, and even more preferably 0.3% by mass or less.
本発明の固体浴用剤中、成分(D)に対する成分(A)及び成分(C)の合計の質量比[{(A)+(C)}/(D)]は、浴水中で速やかに発泡させる観点、及び、成分(C)に由来する良好な冷涼感をもたらす観点から、50以上であり、好ましくは65以上であり、より好ましくは100以上であり、さらに好ましくは250以上である。また、当該質量比[{(A)+(C)}/(D)]は、入浴時のむせを抑制する観点から、1000以下であり、好ましくは930以下であり、より好ましくは450以下であり、さらに好ましくは350以下である。 In the solid bath agent of the present invention, the mass ratio of the sum of component (A) and component (C) to component (D) [{(A)+(C)}/(D)] is such that foaming occurs rapidly in bath water. From the viewpoint of providing a good cooling sensation derived from component (C), it is 50 or more, preferably 65 or more, more preferably 100 or more, and still more preferably 250 or more. In addition, the mass ratio [{(A)+(C)}/(D)] is 1000 or less, preferably 930 or less, and more preferably 450 or less, from the viewpoint of suppressing choking during bathing. Yes, and more preferably 350 or less.
本発明の固体浴用剤中、成分(D)に対する成分(C)の質量比[(C)/(D)]は、入浴時のむせを抑制する観点から、好ましくは0.05以上であり、より好ましくは0.1以上であり、さらに好ましくは0.5以上であり、さらにより好ましくは1.2以上である。また、当該質量比[(C)/(D)]は、入浴時のむせを抑制する観点、及び、良好な清涼感をもたらす観点から、好ましくは12以下であり、より好ましくは10以下であり、さらに好ましくは8以下であり、さらにより好ましくは6以下である。 In the solid bath agent of the present invention, the mass ratio of component (C) to component (D) [(C)/(D)] is preferably 0.05 or more from the viewpoint of suppressing choking during bathing, It is more preferably 0.1 or more, still more preferably 0.5 or more, and even more preferably 1.2 or more. In addition, the mass ratio [(C)/(D)] is preferably 12 or less, more preferably 10 or less, from the viewpoint of suppressing choking during bathing and providing a good refreshing feeling. , more preferably 8 or less, even more preferably 6 or less.
<成分(E):25℃で固体の水溶性高分子>
本発明の固体浴用剤は、包材開封時のむせを抑制する観点から、成分(E)として25℃で固体の水溶性高分子を含有する。なお、本発明において、水溶性高分子とは、25℃の純水100gに対して0.5質量%以上溶解する高分子化合物をいい、25℃で固体であるとは、軟化点又は融点が30℃以上を示すことと同義である。
<Component (E): Water-soluble polymer that is solid at 25°C>
The solid bath preparation of the present invention contains a water-soluble polymer that is solid at 25° C. as component (E) from the viewpoint of suppressing choking when the packaging material is opened. In the present invention, a water-soluble polymer refers to a polymer compound that dissolves at least 0.5% by mass in 100 g of pure water at 25°C, and being solid at 25°C means that the softening point or melting point is It has the same meaning as indicating a temperature of 30°C or higher.
当該水溶性高分子としては、例えば、ポリエチレングリコール、ポリビニルピロリドン、ポリエチレンイミン、ポリビニルアルコール等の合成水溶性高分子;にかわ、ゼラチン、コラーゲンタンパク、カゼイン、アルギン酸ナトリウム、カラギーナン、ファーセレラン、タマリンドガム、ペクチン、アラビアガム、グアーガム、キサンタンガム、トラガントガム、ローカストビーンガム、デキストリン、デキストラン、寒天、澱粉等の天然水溶性高分子;カルボキシメチルセルロース、メチルセルロース、ヒドロキシエチルセルロース、ヒドロキシプロピルセルロース、酢酸フタル酸セルロース、アルギン酸プロピレングリコールエステル、酸化澱粉、エステル化澱粉、エーテル化澱粉、カチオン澱粉等の半合成水溶性高分子;等のうち25℃で固体のものが挙げられ、これらのうち1種又は2種以上を含有することができる。なかでも、包材開封時のむせを抑制し、優れた保存安定性を付与する観点から、ポリエチレングリコール及びデキストリンからなる群から選ばれる1種又は2種が好ましく、ポリエチレングリコールがより好ましい。ポリエチレングリコールの分子量は、好ましくは4,000以上10,000以下であり、より好ましくは5,000以上9,000以下である。 Examples of the water-soluble polymers include synthetic water-soluble polymers such as polyethylene glycol, polyvinylpyrrolidone, polyethyleneimine, and polyvinyl alcohol; glue, gelatin, collagen protein, casein, sodium alginate, carrageenan, furcellan, tamarind gum, pectin, Natural water-soluble polymers such as gum arabic, guar gum, xanthan gum, tragacanth gum, locust bean gum, dextrin, dextran, agar, starch; carboxymethyl cellulose, methyl cellulose, hydroxyethyl cellulose, hydroxypropyl cellulose, cellulose acetate phthalate, alginate propylene glycol ester, Semi-synthetic water-soluble polymers such as oxidized starch, esterified starch, etherified starch, cationic starch, etc., which are solid at 25°C, may contain one or more of these. . Among these, from the viewpoint of suppressing choking when opening the packaging material and imparting excellent storage stability, one or two selected from the group consisting of polyethylene glycol and dextrin are preferred, and polyethylene glycol is more preferred. The molecular weight of polyethylene glycol is preferably 4,000 or more and 10,000 or less, more preferably 5,000 or more and 9,000 or less.
本発明の固体浴用剤中の成分(E)の含有量は、包材開封時のむせを抑制する観点から、好ましくは0.01質量%以上、より好ましくは0.05質量%以上、さらに好ましくは0.3質量%以上である。また、成分(E)の含有量は、炭酸ガス発生量を確保して良好な温まり速さ及び発泡性を付与する観点から、好ましくは15質量%以下、より好ましくは9質量%以下、さらに好ましくは3質量%以下である。 The content of component (E) in the solid bath agent of the present invention is preferably 0.01% by mass or more, more preferably 0.05% by mass or more, and even more preferably is 0.3% by mass or more. In addition, the content of component (E) is preferably 15% by mass or less, more preferably 9% by mass or less, and even more preferably is 3% by mass or less.
本発明の固体浴用剤において、成分(E)に対する成分(C)の質量比[(C)/(E)]は、成分(C)に由来する良好な冷涼感をもたらす観点から、0.01以上であり、好ましくは0.05以上、より好ましくは0.1以上、さらに好ましくは0.3以上、よりさらに好ましくは0.4以上である。また、包材開封時のむせを抑制する観点から、10以下であり、好ましくは5以下であり、より好ましくは4以下、さらに好ましくは3以下であり、よりさらに好ましくは1.2以下である。 In the solid bath agent of the present invention, the mass ratio [(C)/(E)] of component (C) to component (E) is 0.01 from the viewpoint of providing a good cooling sensation derived from component (C). or more, preferably 0.05 or more, more preferably 0.1 or more, still more preferably 0.3 or more, even more preferably 0.4 or more. In addition, from the viewpoint of suppressing choking when opening the packaging material, it is 10 or less, preferably 5 or less, more preferably 4 or less, even more preferably 3 or less, and even more preferably 1.2 or less. .
本発明の固体浴用剤には、その他の成分として、通常浴用剤に用いられる成分を適宜含有することができる。かかる成分としては、例えば、ショ糖脂肪酸エステルやポリエチレングリコール脂肪酸エステル、ポリオキシエチレンアルキルエーテル、ポリオキシエチレン硬化ヒマシ油等のノニオン界面活性剤、及びその他の界面活性剤;硫酸ナトリウム、硫酸マグネシウム、塩化カリウム、塩化ナトリウム、硝酸カリウム、硝酸ナトリウム、ポリリン酸ナトリウム、塩化アンモニウム、硫酸鉄、リン酸ナトリウム、チオ硫酸ナトリウム等の、上記成分以外の無機塩;ケイ酸カルシウム、ブドウ糖等の賦形剤;崩壊助剤;生薬等の薬効成分;色素;香料(前記成分(C)及び成分(D)を除く);油剤;等が挙げられる。 The solid bath additive of the present invention may appropriately contain other components that are commonly used in bath additives. Such components include, for example, nonionic surfactants such as sucrose fatty acid ester, polyethylene glycol fatty acid ester, polyoxyethylene alkyl ether, polyoxyethylene hydrogenated castor oil, and other surfactants; sodium sulfate, magnesium sulfate, and chloride. Inorganic salts other than the above ingredients such as potassium, sodium chloride, potassium nitrate, sodium nitrate, sodium polyphosphate, ammonium chloride, iron sulfate, sodium phosphate, sodium thiosulfate; Excipients such as calcium silicate and glucose; Disintegration aids agents; medicinal ingredients such as crude drugs; pigments; fragrances (excluding the above-mentioned components (C) and (D)); oils; and the like.
香料(前記成分(C)及び成分(D)を除く)には浴用剤に用い得るものであれば特に制限されず、種々の香料成分を含有することができる。
かかる香料としては、例えば、「合成香料 化学と商品知識」(印藤元一著、化学工業日報社、2005年増補改定版)に記載の香料等、すなわちミルセン、オシメン、カンフェン、ターピノレン、アルファーターピネン、フェランドレン、アルファフェランドレン、パラサイメン、ファルネセン、セドレン、ロンジフォレン、コパエン、グアイエン、パチョレン、グルジュネン、リモネン、シトラール、テルピネン等のテルペン系炭化水素又はセスキテルペン系炭化水素の香料;
アルコール系香料、アルデヒド系香料、ケトン系香料、エーテル系香料、オキサイド系香料、エステル系香料、ラクトン系香料等から選ばれる1種又は2種以上が挙げられる。
また、これら香料は、所望の香りに合わせて種々の調合香料として含有することもできる。
The fragrance (excluding the above-mentioned components (C) and (D)) is not particularly limited as long as it can be used in bath preparations, and can contain various fragrance components.
Such fragrances include, for example, the fragrances described in "Synthetic Fragrances Chemistry and Product Knowledge" (written by Genichi Indo, published by Kagaku Kogyo Nippo, revised and revised edition in 2005), such as myrcene, ocimene, camphene, terpinolene, and alpha-terpinene. , terpene-based hydrocarbon or sesquiterpene-based hydrocarbon fragrances such as phellandrene, alpha-phellandrene, paracymene, farnesene, cedrene, longifolene, copaene, guaien, pacholene, glujunene, limonene, citral, terpinene;
Examples include one or more types selected from alcohol-based fragrances, aldehyde-based fragrances, ketone-based fragrances, ether-based fragrances, oxide-based fragrances, ester-based fragrances, lactone-based fragrances, and the like.
Moreover, these fragrances can also be contained as various mixed fragrances depending on the desired fragrance.
(剤型)
本発明の固体浴用剤の使用時の剤型(製品形態)としては、錠剤が好ましい。錠剤には、打錠剤やブリケット型剤が含まれ、発泡持続性の観点からは打錠剤であることがより好ましい。
本発明の固体浴用剤が打錠剤又はブリケット型剤である場合、プレス打錠機やブリケットマシーンを用いて圧縮成形法等の常法に従って製造することができる。
打錠剤又はブリケット型剤の製造においては、例えば、本発明の固体浴用剤を構成する全成分をドライブレンドして得られた粉末を圧縮成形に供してもよく、成分の一部を予め造粒あるいは成型した後、残りの成分と混合して得られた混合物を圧縮成形に供してもよい。
(Dosage form)
The preferred dosage form (product form) for use of the solid bath preparation of the present invention is a tablet. Tablets include compressed tablets and briquette-type preparations, and compressed tablets are more preferable from the viewpoint of sustained foaming.
When the solid bath preparation of the present invention is in the form of tablets or briquettes, it can be manufactured by conventional methods such as compression molding using a tablet press or briquette machine.
In the production of compressed tablets or briquettes, for example, a powder obtained by dry blending all the components constituting the solid bath preparation of the present invention may be subjected to compression molding, or some of the components may be granulated in advance. Alternatively, after molding, the resulting mixture may be mixed with the remaining components and subjected to compression molding.
(発泡性固体浴用剤製品)
本発明の発泡性固体浴用剤製品は、本発明の固体浴用剤を包材に封入してなるものであり、該製品における包材を開封した際にむせを抑制することができる。
包材の形状は、本発明の固体浴用剤を封入できる構造を有するものであれば特に制限はなく、例えば袋状、ボトル状、トレー状、カップ状等が挙げられる。これらの中でも袋状の包材が好ましい。
包材を構成する材質も、本発明の固体浴用剤を封入できるものであれば特に制限はない。例えば袋状包材の場合は、樹脂フィルム、又は樹脂フィルム上に金属又は金属酸化物からなる無機薄膜を積層した積層フィルム等を用いることができる。
(Foaming solid bath agent products)
The foamable solid bath agent product of the present invention is made by encapsulating the solid bath agent of the present invention in a packaging material, and can suppress choking when the packaging material of the product is opened.
The shape of the packaging material is not particularly limited as long as it has a structure that can enclose the solid bath agent of the present invention, and examples thereof include a bag shape, a bottle shape, a tray shape, a cup shape, and the like. Among these, bag-shaped packaging materials are preferred.
The material constituting the packaging material is not particularly limited as long as it can enclose the solid bath agent of the present invention. For example, in the case of a bag-like packaging material, a resin film or a laminated film in which an inorganic thin film made of metal or metal oxide is laminated on a resin film can be used.
以下、本発明を実施例により説明するが、本発明は実施例の範囲に限定されない。 EXAMPLES Hereinafter, the present invention will be explained with reference to examples, but the present invention is not limited to the scope of the examples.
実施例1~14、比較例1~2(固体浴用剤の製造及び評価)
表1に示す各成分を混合して得られた粉末を用いて、ロータリー打錠機にて、質量69~71g、錠高19.3~19.5mmのサイズにて、打錠速度20錠/分で打錠を行い、錠剤(打錠剤)型の固体浴用剤を製造した。また、下記方法にて開封時のむせ、及び入浴時のむせを評価した。結果を表1に示す。なお、表1に記載の含有量はいずれも有効成分量(質量%)である。
Examples 1 to 14, Comparative Examples 1 to 2 (manufacture and evaluation of solid bath additives)
Using a powder obtained by mixing the ingredients shown in Table 1, a rotary tablet machine was used to make tablets with a mass of 69 to 71 g and a tablet height of 19.3 to 19.5 mm at a compression speed of 20 tablets/ The mixture was compressed into tablets to produce tablet-shaped solid bath preparations. In addition, choking upon opening the package and choking upon bathing were evaluated using the following method. The results are shown in Table 1. Note that all the contents listed in Table 1 are active ingredient amounts (% by mass).
<開封時のむせの評価>
各例の固体浴用剤70g(1錠)を包材としてアルミピロー(大日本印刷(株)製、9cm×11cm)に入れて封入することにより作製した固体浴用剤製品を、室温で24時間放置した後、専門パネラー1名が包材を開封した時に開封口に顔を近づけ、開封時に発生する「むせ」を下記基準にしたがって評価した。
A:マイルドな香りを感じ、かつ全くむせない
B:マイルドな香りを感じ、かつ一時的にわずかにむせる
C:香りにわずかな刺激を感じ、かつ少しむせる
D:香りに強い刺激を感じ、かつとてもむせる
<Evaluation of choking upon opening>
A solid bath agent product was prepared by enclosing 70 g (1 tablet) of the solid bath agent of each example in an aluminum pillow (manufactured by Dainippon Printing Co., Ltd., 9 cm x 11 cm) and left at room temperature for 24 hours. After opening the packaging material, one expert panelist brought his/her face close to the opening and evaluated the "choking" that occurred when opening the packaging material according to the following criteria.
A: I feel a mild scent, and I don't choke at all B: I feel a mild scent, and I temporarily feel slightly choked C: I feel a slight irritation from the scent, and I choke a little D: I feel a strong irritation from the scent, and very suffocating
<入浴時のむせの評価>
浴槽に40℃の浴水150Lを入れ、専門パネラー1名を浴水に肩まで浸かるように入浴させながら各例の固体浴用剤70g(1錠)を投入して、固体浴用剤の溶解終了までに発生する「むせ」を、下記基準にしたがって評価した。
A:マイルドな香りを感じ、かつ全くむせない
B:マイルドな香りを感じ、かつ一時的にわずかにむせる
C:香りにわずかな刺激を感じ、かつ少しむせる
D:香りに強い刺激を感じ、かつとてもむせる
<Assessment of choking during bathing>
Pour 150L of 40°C bath water into a bathtub, have one expert panelist take a bath up to his shoulders, and add 70g (1 tablet) of each solid bath preparation until the solid bath preparation is completely dissolved. The ``suffocation'' that occurs in patients was evaluated according to the following criteria.
A: I feel a mild scent, and I don't choke at all B: I feel a mild scent, and I temporarily feel slightly choked C: I feel a slight irritation from the scent, and I choke a little D: I feel a strong irritation from the scent, and very suffocating
<発泡性の評価>
浴槽に40℃の浴水150Lを入れ、各例の固体浴用剤70g(1錠)を投入して、速やかに専門パネラー1名を入浴させ、浴用剤投入30秒後の「発泡性」を、下記基準にしたがって評価した。
A:発泡が非常に強い
B:発泡がやや強い
C:発泡が弱い
<Evaluation of foamability>
Pour 150 L of 40°C bath water into a bathtub, add 70 g (1 tablet) of each solid bath agent, and immediately have one expert panelist take a bath. Evaluation was made according to the following criteria.
A: Very strong foaming B: Slightly strong foaming C: Weak foaming
表1中、*1~*6は下記のとおりである。
*1:l-メントール、高砂香料工業(株)製「メントール JP COS」、有効成分100%
*2:サリチル酸メチル、(株)井上香料製造所製「Methyl Salicylate」、有効成分100%
*3:ポリエチレングリコール、花王(株)製「K-PEG6000 LA」、分子量6,000
*4:デキストリン、日澱化学(株)製「デキストリン CZRM-X」
*5:香料成分、前記成分(C)及び成分(D)以外の香料成分(調合香料)
*6:ブドウ糖、日本食品化工(株)製「無水結晶ぶどう糖」
In Table 1, *1 to *6 are as follows.
*1: L-menthol, "Menthol JP COS" manufactured by Takasago International Corporation, 100% active ingredient
*2: Methyl Salicylate, manufactured by Inoue Fragrance Manufacturing Co., Ltd., 100% active ingredient
*3: Polyethylene glycol, “K-PEG6000 LA” manufactured by Kao Corporation, molecular weight 6,000
*4: Dextrin, “Dextrin CZRM-X” manufactured by Nippon Star Chemical Co., Ltd.
*5: Fragrance ingredients, fragrance ingredients other than the above-mentioned component (C) and component (D) (compounded perfume)
*6: Glucose, “Anhydrous Crystalline Glucose” manufactured by Nihon Shokuhin Kako Co., Ltd.
表1より、本発明の固体浴用剤は入浴時のむせ、及び、包材中に封入した固体浴用剤製品を開封した際のむせを抑制することができることがわかる。 Table 1 shows that the solid bath preparation of the present invention can suppress choking during bathing and choking when opening the solid bath preparation product sealed in the packaging material.
本発明によれば、l-メントール等による冷涼感が得られ、浴水中での発泡が速く、かつ、包材開封時及び入浴時のむせが抑制された発泡性固体浴用剤、及び該発泡性固体浴用剤を包材に封入した発泡性固体浴用剤製品を提供できる。 According to the present invention, there is provided a foaming solid bath agent that provides a cooling sensation due to l-menthol, etc., foams quickly in bath water, and suppresses choking when opening a packaging material and when taking a bath; It is possible to provide a foamable solid bath agent product in which a solid bath agent is encapsulated in a packaging material.
Claims (6)
(A)20℃の水100mLへの溶解度が5g以上である有機酸(A1)を含む有機酸 10質量%以上70質量%以下
(B)炭酸塩
(C)l-メントール、乳酸メンチル、酢酸メンチル、及びメントンからなる群から選ばれる1種以上 0.1質量%以上1.5質量%以下
(D)サリチル酸メチル 0.05質量%以上0.5質量%以下
(E)25℃で固体の水溶性高分子 0.1質量%以上3質量%以下
を含有し、
成分(D)に対する成分(A)及び成分(C)の合計の質量比[{(A)+(C)}/(D)]が50以上1000以下であり、成分(E)に対する成分(C)の質量比[(C)/(E)]が0.01以上10以下である、発泡性固体浴用剤。 The following components (A), (B), (C), (D), and (E):
(A) Organic acid containing organic acid (A1) having a solubility in 100 mL of water at 20°C of 5 g or more , 10% by mass or more and 70% by mass or less
(B) Carbonate (C) One or more selected from the group consisting of l-menthol, menthyl lactate, menthyl acetate, and menthone 0.1% by mass or more and 1.5% by mass or less
(D) Methyl salicylate 0.05% by mass or more and 0.5% by mass or less
(E) Water-soluble polymer that is solid at 25°C 0.1% by mass or more and 3% by mass or less
Contains
The mass ratio of the sum of component (A) and component (C) to component (D) [{(A)+(C)}/(D)] is 50 or more and 1000 or less, and the component (C) to component (E) is ) A foaming solid bath agent having a mass ratio [(C)/(E)] of 0.01 or more and 10 or less.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2019158607A JP7382766B2 (en) | 2019-08-30 | 2019-08-30 | Foaming solid bath additive |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2019158607A JP7382766B2 (en) | 2019-08-30 | 2019-08-30 | Foaming solid bath additive |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2021038151A JP2021038151A (en) | 2021-03-11 |
JP7382766B2 true JP7382766B2 (en) | 2023-11-17 |
Family
ID=74848179
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2019158607A Active JP7382766B2 (en) | 2019-08-30 | 2019-08-30 | Foaming solid bath additive |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP7382766B2 (en) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2016113402A (en) | 2014-12-16 | 2016-06-23 | 花王株式会社 | Bath agent composition |
-
2019
- 2019-08-30 JP JP2019158607A patent/JP7382766B2/en active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2016113402A (en) | 2014-12-16 | 2016-06-23 | 花王株式会社 | Bath agent composition |
Also Published As
Publication number | Publication date |
---|---|
JP2021038151A (en) | 2021-03-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2001506533A (en) | Composition for fragrance release | |
JP2015182983A (en) | Dentifrice composition | |
CN117642084A (en) | Supported nicotine compositions | |
JPS609009B2 (en) | Foaming bath agent | |
JP7217167B2 (en) | Solid bath agent | |
JP2013129600A (en) | Dentifrice composition | |
JP5492871B2 (en) | Pectin-containing jelly preparation | |
JP7382766B2 (en) | Foaming solid bath additive | |
JP7335758B2 (en) | Effervescent solid bath agent | |
KR20220162136A (en) | Compositions containing menthol | |
JP5670660B2 (en) | Bath agent composition | |
JP3967028B2 (en) | Bath agent composition | |
JP5894792B2 (en) | Solid bath agent | |
JP2000297007A (en) | Foaming cosmetic | |
JP2014214107A (en) | Dentifrice composition | |
JP7155943B2 (en) | Liquid oral compositions and oral spray formulations | |
JP6209323B2 (en) | Effervescent compression formulation | |
JP2000510384A (en) | Method for fragrance release | |
JP4643784B2 (en) | Bath agent composition | |
WO2018221612A1 (en) | Liquid composition for oral cavity | |
JP2015113320A (en) | Bathing agent composition | |
JP2008162923A (en) | Method for producing bathing agent | |
JP4348208B2 (en) | Compression mold bath agent | |
JP5512382B2 (en) | Powder bath | |
TWI740832B (en) | Liquid oral composition in bubble spray container |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20220615 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20230421 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20230425 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20230623 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20230807 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20231017 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20231107 |
|
R151 | Written notification of patent or utility model registration |
Ref document number: 7382766 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R151 |